Roberto Caricchio to Fibrin Fibrinogen Degradation Products
This is a "connection" page, showing publications Roberto Caricchio has written about Fibrin Fibrinogen Degradation Products.
Connection Strength
0.372
-
Caricchio R, Abbate A, Gordeev I, Meng J, Hsue PY, Neogi T, Arduino R, Fomina D, Bogdanov R, Stepanenko T, Ruiz-Seco P, G?nzalez-Garc?a A, Chen Y, Li Y, Whelan S, Noviello S. Effect of Canakinumab vs Placebo on Survival Without Invasive Mechanical Ventilation in Patients Hospitalized With Severe COVID-19: A Randomized Clinical Trial. JAMA. 2021 07 20; 326(3):230-239.
Score: 0.191
-
Rali P, O'Corragain O, Oresanya L, Yu D, Sheriff O, Weiss R, Myers C, Desai P, Ali N, Stack A, Bromberg M, Lubitz AL, Panaro J, Bashir R, Lakhter V, Caricchio R, Gupta R, Dass C, Maruti K, Lu X, Rao AK, Cohen G, Criner GJ, Choi ET. Incidence of venous thromboembolism in coronavirus disease 2019: An experience from a single large academic center. J Vasc Surg Venous Lymphat Disord. 2021 05; 9(3):585-591.e2.
Score: 0.181